melanotan drug (MT)-II | Melanotropin Receptor Agonist Melanotan II, also known as

doi: 10.1016/j.jbiotec.2011.09.022

Metabolic syndrome and risk factors for non-alcoholic fatty liver disease

Injectable Formulation: The intravenous dose recommended is 600 to 1200 mg once or twice a week, but various adverse effects are reported with the intravenous route due to the possibilities of overdose toxicities or may be due to additives present in glutathione injections

Do not use InjectaMax Injection with another form of copper or selenium supplementation, or administer at the same time as other treatments such as at drenching or vaccination

This insight helps your PlexusDx clinician personalize your treatment protocol for maximum efficacy and faster results

Motallebipour M, Rada-Iglesias A, Jansson M, Wadelius C